PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes |
| Sentences | 529 |
| PubMedID- 22125626 | The relationship between vascular diseases and hua in patients with type 2 diabetes has not been fully explored. |
| PubMedID- 22891922 | Postprandial hyperglycemia is a major risk factor for morbidity and mortality from cardiovascular disease in diabetes [1,2]. |
| PubMedID- 22870927 | Among 1849 subjects, 669 (mean age 55.3+/-8.8 years; 392 men) with ft4 and tsh in the normal ranges were included after excluding those with diabetes, a history of current smoking and cardiovascular disease (cvd), or the use of drugs for hypertension, antithyroid drugs, or thyroid hormone preparations. |
| PubMedID- 20550690 | The risk factors were presented in the questionnaire in the following order: higher age, hyperlipidemia, diabetes, a family history of cardiovascular disease, atrial fibrillation, hypertension, overweight, regular physical exercise, excessive alcohol consumption, previous stroke/tia, carotid stenosis, smoking and ischaemic heart disease. |
| PubMedID- 23230099 | The macrovascular complications of diabetes, which can lead to cardiovascular diseases, are the major cause of death in patients with type 2 diabetes. |
| PubMedID- 25629920 | A descriptive, cross-sectional survey was undertaken in 1800 individuals without diabetes or a history of cardiovascular disease (cvd). |
| PubMedID- 26107641 | Patients had multiple risk factors at inclusion on renal transplantation waiting list as high blood pressure (94.7%), dyslipidemia (81.1%), smoking (45.3%), diabetes (23.6%), past history of cardiovascular disease (21.3%) and obesity (12.7%). |
| PubMedID- 26353872 | Risk factors included age, body mass index (bmi), systolic blood pressure, cholesterol/ high-density lipoprotein (hdl) ratio, glycosylated haemoglobin (hba1c), material deprivation, ethnicity, smoking, diabetes duration, type of diabetes, atrial fibrillation, cardiovascular disease, chronic renal disease, and family history of premature coronary heart disease. |
| PubMedID- 26239688 | Nevertheless, microalbuminuria is also a risk factor for cardiovascular disease in patients with or without diabetes and currently there exist no tests that can differentiate between these two potential causes [49]. |
| PubMedID- 22247606 | vascular diseases associated with hypercholesterolemia, diabetes and hypertension are characterized by endothelial dysfunction and reduced endothelium-mediated vasodilation. |
| PubMedID- 21501602 | Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. |
| PubMedID- 24416433 | Several clinical studies were also performed to investigate the safety of dpp4 inhibitors on diabetes with cardiovascular disease. |
| PubMedID- 23431014 | diabetes doubles the risk of cardiovascular disease (cvd) independently of other risk factors (1). |
| PubMedID- 20332353 | The excess morbidity and mortality experienced by people with type 2 diabetes is primarily due to increased cardiovascular disease (cvd) risk, and this risk is in turn driven by the triad of hyperglycemia, hypertension, and hyperlipidemia (2). |
| PubMedID- 24623985 | Macrovascular disease in diabetes corresponds to the atherosclerotic damage in the blood vessels, which limits blood flow to the penis. |
| PubMedID- 26207061 | Patient empowerment programme (pep) and risk of microvascular diseases among patients with type 2 diabetes in primary care: a population-based propensity-matched cohort study. |
| PubMedID- 22615952 | Model 1: adjusted for age, bmi, current smoking, alcohol intake, exercise, diabetes mellitus, history of cardiovascular disease and history of malignancy. |
| PubMedID- 22762006 | Hypertension (htn), obesity, hyperlipidemia, and cigarette smoking act as independent modifiable contributors to cardiovascular disease (cvd) in patients with diabetes [3]. |
| PubMedID- 22301122 | For example, cardiac autonomic dysfunction is a risk factor for cardiovascular diseases in diabetes (3,17) and is usually diagnosed according to impaired hrv (1,18). |
| PubMedID- 20701768 | Risk factor reduction is the most important therapy for primary and secondary prevention of macrovascular disease in patients with and without diabetes mellitus. |
| PubMedID- 22184101 | Study selection: a study was eligible when it described the development, validation or impact assessment of a model that was constructed to predict the occurrence of cardiovascular disease in people with type 2 diabetes, or when the model was designed for use in the general population but included diabetes as a predictor. |
| PubMedID- 24843558 | Hazard ratios for cardiovascular disease in patients with diabetes classified according to (a) the standard deviation (sd) and mean hba1c and (b) the coefficient of variation (cv) and mean of hba1c during the follow‐up period. |
| PubMedID- 26130877 | Winners in each category were as follows: best fellow poster, "diet pattern and cardiovascular disease among women with type 2 diabetes mellitus," by hyun joon shin, md; best resident poster, "oral squamous cell carcinoma: current concepts in imaging, staging, and fibular osteocutaneous free-flap reconstruction," by r. |
| PubMedID- 23772277 | Atherosclerotic cardiovascular disease among patients with type 2 diabetes in basrah. |
| PubMedID- 22844422 | Although most early studies so far have been concerned by the concept that factors secreted from the gut endocrine system participate in the regulation of gastrointestinal functions, growing evidence underlines their functions in metabolic pathways and in the pathophysiology of various metabolic diseases, including obesity, insulin resistance and diabetes, which lead to cardiovascular diseases. |
| PubMedID- 24688225 | In t2dm smoking cigarettes may protect against the progression of retinopathy in some patients, despite the fact that it is an independent risk factor for myocardial infarction and death from cardiovascular disease in patients with diabetes [45]. |
| PubMedID- 24158454 | The framingham stroke prediction algorithm (http://www.framinghamheartstudy.org/risk/stroke.html) included sbp values and age, diabetes mellitus, smoking, history of cardiovascular disease, presence of atrial fibrillation, left ventricular hypertrophy and the use of hypertensive medication. |
| PubMedID- 26429401 | We did a nationwide study in sweden to examine risks of cardiovascular disease and mortality in patients with obesity and diabetes who had undergone bariatric surgery (roux-en-y gastric bypass [rygb]). |
| PubMedID- 23466074 | Role of relationship between hba1c, fibrinogen and hdl-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24617860 | Context: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus (dm). |
| PubMedID- 23717466 | Insulin resistance (ir), a pathogenic factor for type 2 diabetes [1], is associated with various cardiovascular disease risk factors, including obesity, hypertension and dyslipidemia [2]. |
| PubMedID- 25609989 | Age-standardized cardiovascular mortality has declined by 20%; however, when associated with diabetes, the mortality due to cardiovascular disease increased by 2% (figure 5). |
| PubMedID- 20934769 | Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24918803 | Interventions targeted at modifiable risk factors, such as smoking cessation and management of hypertension and dyslipidemia, reduce the risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23113179 | Therefore, higher rates of cardiovascular disease because of type 2 diabetes, among people with lower socioeconomic characteristics are expected and demonstrated in several studies (8, 20). |
| PubMedID- 26244041 | A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) [6]. |
| PubMedID- 25893104 | Another meta-analysis explored the efficacy of acei and arb in the prevention of cardiovascular disease (cvd) in patients with diabetes and hypertension.17 compared to placebo or other active treatment, in 23 studies with 32 827 patients with diabetes, acei significantly reduced the risk of all-cause mortality by 13% (rr 0.87; 95% ci 0.78 to 0.98), the incidence of cv deaths by 17% (0.83; 0.70 to 0.99), major cv events by 14% (0.86; 0.77 to 0.95), including myocardial infarction by 21% (0.79; 0.65 to 0.95) and heart failure by 19% (0.81; 0.71 to 0.93). |
| PubMedID- 23745805 | Micrornas: biomarkers for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 23547796 | Predisposing factors such as diabetes and immunosuppression lead to vascular disease and suppressed immunity that increase susceptibility to polymicrobial infection. |
| PubMedID- 23306779 | Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome. |
| PubMedID- 23742753 | Points were assigned as follows: two for recent hospitalization or icu admission; one each for age < 30 or > 79 years, prior iv antibiotic exposure, dementia, cerebrovascular disease, female with diabetes, or recent exposure to a nursing home/long term acute care facility/skilled nursing facility. |
| PubMedID- 22340758 | Cardiovascular diseases (cvd) in patients with type 2 diabetes are a large and increasing health problem. |
| PubMedID- 25877139 | Objective: to investigate if a six-year intensive lifestyle intervention in people with pre-diabetes lead to reduction of cardiovascular events and cardiovascular disease (cvd) mortality in subsequent 23 years. |
| PubMedID- 24126880 | Therefore, we evaluate coronary arteries as well as coronary microvascular disease (associated with diabetes and hypertension), suspected or overt dilated cardiomyopathy, systolic and diastolic heart failure, hypertrophic cardiomyopathy, athletes' hearts, valvular heart disease, congenital heart disease, incipient or overt pulmonary hypertension, and heart transplant patients for early detection of chronic or acute rejection as well as potential donors for better selection of suitable donor hearts. |
| PubMedID- 23050905 | Half of all deaths from diabetes are due to cardiovascular disease and stroke[23]. |
| PubMedID- 23275938 | [25] proposed that the cut-off point for the bapwv in type 2 diabetes patients with cardiovascular disease was 1,635 cm/sec (sensitivity 73%, specificity 75%). |
| PubMedID- 26314713 | As a result, more hiv-infected patients die of cardiovascular diseases, with diabetes being one of the main risk factors. |
| PubMedID- 26173772 | Confounders for this association were age, ethnicity, season, sun exposure, diabetes duration, presence of cardiovascular disease, egfr, alkaline phosphatase and ldl cholesterol. |
| PubMedID- 24757888 | The prevalence of many of the co-morbidities assessed is statistically the same in pre-diabetes patients with only peripheral vascular disease, eye disease and cerebrovascular disease having a statistically significant higher prevalence in type 2 diabetes. |
| PubMedID- 20653939 | On the contrary, if the patient did not control blood sugar level well and it is highly possible that diabetes was the perpetrator of cardiovascular diseases, then the certifiers could enter diabetes in part i of the death certificate. |